Complex Regional Pain Syndrome News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Abbott launches dorsal root ganglion neurostim system in Europe
Abbott (NYSE:ABT) said today that it launched its Proclaim dorsal root ganglion neurostimulation system in Europe for patients suffering from chronic neuropathic pain. The Abbott Park, Il.-based company’s system targets sensory nerves packed within the dorsal root ganglion to directly target the area of the body where pain occurs and provide stronger pain relief compared to traditional spinal cord stimulation therapy. “Many patients battling chronic neuropathic pain have not found adequate relief from other forms of treatment, which is why dorsal root ganglion stimulation has been such an important therapeutic ...
Source: Mass Device - January 18, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Neuromodulation/Neurostimulation Pain Management Regulatory/Clearance Wall Street Beat Abbott Source Type: news

MassDevice.com +5 | The top 5 medtech stories for January 17, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters. 5. FDA warns again on Pentax duodenoscopes The FDA issued a statement today warning that Hoya subsidiary Pentax Medical’s ED-3490TK video duodenoscopes have a potential risk associated with the design and manufacturing of the de...
Source: Mass Device - January 17, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Abbott touts dorsal root ganglion stim study
Abbott (NYSE:ABT) today touted short- and long-term data published in the journal Pain, which demonstrated that its dorsal root ganglion stimulation therapy benefits patients suffering from complex regional pain syndrome more than traditional spinal cord stimulation. The Abbott Park, Ill.-based company said it’s the only company in the world approved to offer DRG stimulation. The newly-published data is from the company’s ACCURATE study, which evaluated DRG stimulation in patients for 3 and 12 months. “Historically, many patients with chronic pain resulting from complex regional pain syndrome or pain re...
Source: Mass Device - January 17, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Pain Management Research & Development Spinal Abbott Source Type: news

New Data Confirms Abbott's Dorsal Root Ganglion Stimulation Offers Greater Treatment Success over Traditional Spinal Cord Stimulation
ACCURATE STUDY CONFIRMS DRG STIMULATION PROVIDES SUPERIOR, TARGETED AND CONSISTENT PAIN RELIEF FOR PATIENTS WITH COMPLEX REGIONAL PAIN SYNDROME (Source: Abbott.com)
Source: Abbott.com - January 17, 2017 Category: Pharmaceuticals Source Type: news

The relation between reflex sympathetic dystrophy syndrome and trauma severity in patients with distal tibia fracture - Bahador R, Mirbolook A, Arbab S, Derakhshan P, Gholizadeh A, Abedi S.
BACKGROUND: Reflex sympathetic dystrophy (RSD) syndrome is a multifactorial disorder with clinical features of neurogenic inflammation that causes hypersensitivity to pain or severe allodynia as well as blood flow problems, swelling, skin discoloration and... (Source: SafetyLit)
Source: SafetyLit - January 5, 2017 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Grünenthal Receives Breakthrough Therapy Designation From U.S. FDA for Neridronic Acid for the Treatment of CRPS
Grünenthal receives Breakthrough Therapy Designation from U.S. FDA for neridronic acid for the treatment of complex regional pain syndrome (CRPS), a debilitating orphan disease with high medical need Neridronic acid is the first investigational med... Biopharmaceuticals, FDA Grünenthal, Abiogen Pharma, neridronic acid, CRPS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 16, 2016 Category: Pharmaceuticals Source Type: news

Medical News Today: Complex regional pain syndrome: Watching others causes pain
For patients with complex regional pain syndrome, simply watching someone else move can cause intense pain. An MRI scan study delves into the neuroscience. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 2, 2016 Category: Consumer Health News Tags: Pain / Anesthetics Source Type: news

Sometimes just watching hurts -- and the signs of pain are seen in the brain
(Aalto University) Some people claim to experience pain just watching something painful to happen. In complex regional pain syndrome (CRPS) patients, both own movements and observing other persons' movements may aggravate the pain. Researchers found that when CRPS patients feel pain caused by observing other person's movements, their brains display abnormal activation in many areas that respond to normal physical pain. Thus the pain the CRPS patients felt during movement observation presented similarities to the 'normal' pain. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 29, 2016 Category: Biology Source Type: news

Sometimes just watching hurts, and the signs of pain are seen in the brain
Some people claim to experience pain just watching something painful to happen. This is true especially of people suffering from complex regional pain syndrome (CRPS), a disabling chronic pain disorder in a limb. In CPRS patients, both own movements and just observing other persons ’ movements may aggravate the pain. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 28, 2016 Category: Science Source Type: news

Thar Pharmaceuticals acquired by German company
Pittsburgh-based Thar Pharmaceuticals has been acquired by Gr ünenthal, a German-based pharmaceutical company. A purchase price wasn't disclosed. Grünenthal said in a statement Wednesday announcing the purchase that Thar's compound, T121, would be used to help expand its own treatment of Complex Regional Pain Syndrome, which is marked by severe and persiste nt pain. The deal includes the worldwide development and commercialization rights for T121. Thar Pharmaceuticals worked to make IV-only drugs… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 16, 2016 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Thar Pharmaceuticals acquired by German company
Pittsburgh-based Thar Pharmaceuticals has been acquired by Gr ünenthal, a German-based pharmaceutical company. A purchase price wasn't disclosed. Grünenthal said in a statement Wednesday announcing the purchase that Thar's compound, T121, would be used to help expand its own treatment of Complex Regional Pain Syndrome, which is marked by severe and persiste nt pain. The deal includes the worldwide development and commercialization rights for T121. Thar Pharmaceuticals worked to make IV-only drugs… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 16, 2016 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

Dorset teenager with an ingrown toenail pays £5k to have her leg amputated
WARNING GRAPHIC CONTENT: Hannah Moore, 19, from Dorset, paid to have her leg amputated after she was diagnosed with complex regional pain syndrome leaving her in agony. (Source: the Mail online | Health)
Source: the Mail online | Health - October 3, 2016 Category: Consumer Health News Source Type: news

Ketamine May Be Useful in Migraine, Chronic Pain Ketamine May Be Useful in Migraine, Chronic Pain
New evidence suggests patients with refractory migraine or complex regional pain syndrome may benefit from treatment with ketamine.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 28, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Artists With 'Invisible' Disabilities Use Tattoos To Talk About Health
“I have chosen a surreal art approach to represent my invisible disability, due to the surreal nature of mental illness,” tattoo artist Lindsay Carter expressed in a statement. Carter’s image ― featured on the right, above ― shows a bird whose head is a cage with a giant eyeball protruding from the dreamlike vision. “As long as I’ve been consciously aware, I’ve been diagnosed with generalized anxiety disorder and major depressive disorder,” she continued. “Severe episodes can happen for no apparent reason and at that point I cannot help nor snap out of the...
Source: Healthy Living - The Huffington Post - September 6, 2016 Category: Consumer Health News Source Type: news

Complex Regional Pain Syndrome in Children Complex Regional Pain Syndrome in Children
This article describes the incidence and clinical features of complex regional pain syndrome in children.Archives of Disease in Childhood (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 25, 2016 Category: Pathology Tags: Pediatrics Journal Article Source Type: news